Drug companies are still focused on raising prices, but some in the industry realize things need to change

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Colombia Noticias Noticias

Colombia Últimas Noticias,Colombia Titulares

Health care executives gave no indication to bankers and investors at this year's J.P. Morgan Healthcare Conference that their pricing practices would change any time soon.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 729. in CO
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

Liquid or syrup supplements.

Colombia Últimas Noticias, Colombia Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices. Why are they being investigated when Trump claimed that drug prices are at an all time low? I just hope the Democrats don't just waste taxpayer dollars with meaningless politically motivated crap like everyone expects them to. This seems a needed topic, but stay away from political theater Democrats. Just watch the SJC in 2018 if you want to see your embarrassment. Nice to see them investigating actual wrong doing and not just investigating HRC again.
Fuente: CNBC - 🏆 12. / 72 Leer más »

Analysis | The Health 202: Health-care industry preps offense against Medicare-for-AllThe Health 202: Health-care industry preps offense against Medicare-for-All Can't cure patients, that hurts long term profits! It's Tuesday.
Fuente: washingtonpost - 🏆 95. / 72 Leer más »